Multiple sclerosis in adults: management [NG186]
NICE updated November 2019
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment.
Updates relate to use of Sativex (a THC:CBD spray) and gabapentin
